APA (7th ed.) Citation

L, M., SP, P., J, G., M, L., M, N., D, O., . . . Y, Y. (2025). Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis. Journal of Cancer, 16(14), 4047. https://doi.org/10.7150/jca.113258

Chicago Style (17th ed.) Citation

L, Meng, et al. "Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis." Journal of Cancer 16, no. 14 (2025): 4047. https://doi.org/10.7150/jca.113258.

MLA (9th ed.) Citation

L, Meng, et al. "Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis." Journal of Cancer, vol. 16, no. 14, 2025, p. 4047, https://doi.org/10.7150/jca.113258.